Efficacy and Safety of Fosfomycin Plus Imipenem vs. Vancomycin for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Randomized Clinical Trial.

Link to article at PubMed

Efficacy and Safety of Fosfomycin Plus Imipenem vs. Vancomycin for Complicated Bacteremia and Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: A Randomized Clinical Trial.

Clin Microbiol Infect. 2018 Feb 02;:

Authors: Pericàs JM, Moreno A, Almela M, García-de-la-Mària C, Marco F, Muñoz P, Peña C, de Alarcón A, Río AD, Eworo A, Cruceta A, Paré JC, Mestres CA, Miró JM, FOSIMI Investigatoicasrs, Miró JM, Moreno A, Pericàs JM, Ambrosioni J, Tellez A, Hernandez-Meneses M, Río AD, Cervera C, Marco F, Garcia de la Mària C, Armero Y, Almela M, Mestres CA, Paré JC, Fuster D, Cartañá R, Ninot S, Azqueta M, Sitges M, Ramírez J, Brunet M, Soy D, Llopis J, Peña C, Gasch O, Suarez C, Pujol M, Ariza J, Carratalà J, Gudiol F, Muñoz P, Eworo A, Bouza E, de Alarcón A, Gurgui M, Benito N, Losa-Garcia JE, Navas E, Paño-Pardo JR, Loeches B, Arribas JR, Montejo M, Galvez J

PMID: 29408610 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *